Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia

Endocrine
Amanda SierraL M Garcia-Segura

Abstract

The expression of aromatase, the enzyme that transforms testosterone into estradiol, was analyzed by reverse transcriptase polymerase chain reaction in the inferior olive of adult male rats. The expression of this messenger in the inferior olive suggests that this brain area may be able to synthesize estradiol. The neuroprotective role of estradiol in the inferior olive was then assessed in a model of cerebellar ataxia, achieved by the ip administration of 3-acetylpyridine (3-AP). In a first experiment, male Wistar rats were orchidectomized to diminish the plasmatic levels of testosterone, the direct precursor of estradiol. Immediately after castration, animals were implanted with a silicone tube that was either empty or filled with estradiol. One week later, animals were injected with 3-AP. Estradiol treatment resulted in a significant reduction in neuronal death in the olive. In a second experiment, animals were treated with fadrozole, an aromatase inhibitor, to assess the role of endogenous estradiol formation in neuroprotection. The results show that the inhibition of aromatase activity, and therefore the decrease in endogenous estrogen formation, increases the death in inferior olive. In conclusion, this study indicates th...Continue Reading

Citations

May 18, 2005·The Journal of Steroid Biochemistry and Molecular Biology·H V O CarswellI M Macrae
Nov 13, 2003·Progress in Neurobiology·Luis M Garcia-SeguraIñigo Azcoitia
Jan 7, 2011·Biology of Sex Differences·Rhonda Voskuhl
Jul 29, 2010·Journal of Pediatric Endocrinology & Metabolism : JPEM·Manish KumarNita Khurana
Mar 23, 2011·Asian Journal of Andrology·Rohit R DhirRun Wang
Jul 1, 2011·European Journal of Endocrinology·George NoussiosKonstantinos Natsis
Sep 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Seema Tiwari-WoodruffRhonda R Voskuhl
Mar 11, 2010·Journal of Neurotrauma·Justin WagnerDaniel F Kelly
Sep 15, 2012·Frontiers in Neuroendocrinology·Valerie L HedgesPaul G Mermelstein
Apr 17, 2012·Hormones and Behavior·Jana Velíšková, Kara A Desantis
Feb 16, 2011·Neuroscience·I AzcoitiaL M Garcia-Segura
Jun 23, 2009·Journal of the Neurological Sciences·Stefan M Gold, Rhonda R Voskuhl
May 16, 2009·Journal of the Neurological Sciences·Seema Tiwari-Woodruff, Rhonda R Voskuhl
May 10, 2008·Journal of the Neurological Sciences·Jae-Hyeok HeoManho Kim
Apr 12, 2008·Brain Research·Josue G YagueJohn H Morrison
Jul 22, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·James W Simpkins, Meharvan Singh
Oct 13, 2015·Frontiers in Neuroendocrinology·Anat Biegon
Mar 3, 2004·Annals of the New York Academy of Sciences·Inigo AzcoitiaLuis M Garcia-Segura
Mar 24, 2009·The European Journal of Neuroscience·Rory D SpenceLainy B Day
Jul 8, 2008·Journal of Neuroendocrinology·L M Garcia-Segura
Dec 15, 2010·The European Journal of Neuroscience·Iñigo AzcoitiaLuis M Garcia-Segura
Jan 24, 2006·Neuroscience·J G YagueI Azcoitia
Oct 10, 2009·Brain Research·Josue G YagueAlberto Muñoz
Jun 26, 2015·Neurology·Maria G Cersosimo, Eduardo E Benarroch
Nov 27, 2014·Nature Reviews. Neuroscience·Maria-Angeles ArevaloLuis M Garcia-Segura
Jan 1, 2010·Hormone Molecular Biology and Clinical Investigation·Iñigo AzcoitiaLuis M Garcia-Segura
May 13, 2020·International Journal of Molecular Sciences·Cristina V DieniRoberto Panichi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.